文献速递神经核医学

帕金森病纹状体VMAT2降低与非运动症状相关

Decreased Striatal Vesicular Monoamine Transporter Type 2 Correlates With the Nonmotor Symptoms in Parkinson Disease.
PubMed 文献 · Clin Nucl Med · 2019-01-01

本研究纳入37例中度帕金森病患者和21例年龄匹配正常对照,采用F-DTBZ PET/CT测定纹状体各亚区特异性摄取率,并评估非运动症状。结果显示帕金森病患者双侧壳核和尾状核摄取率降低,且除认知外非运动症状评分与纹状体摄取率相关。

要点

  • 帕金森病患者双侧壳核和尾状核VMAT2摄取率较健康对照降低。
  • 除认知外,非运动症状评分与纹状体VMAT2摄取率相关。
  • 纹状体多巴胺供应减少与非运动症状发展相关。

核心结论

  • 帕金森病患者纹状体VMAT2降低与广泛非运动症状相关,提示多巴胺供应减少与非运动症状发展相关。

研究设计与样本

  • 纳入21例年龄匹配正常对照和37例中度帕金森病患者,采用F-DTBZ(F-AV133)PET/CT检查。
  • 以枕叶皮层为参考背景区,测定纹状体各亚区特异性摄取率(SUR)。
  • 评估每例患者整体非运动症状,采用Spearman相关分析和多因素逐步回归分析评价纹状体SUR与临床症状评分的关系。

主要发现

  • 帕金森病患者,尤其是更晚期患者,双侧壳核和尾状核SUR降低更明显(P < 0.05,对比健康对照)。
  • 更晚期帕金森病患者除认知功能外非运动症状评分显著更差。
  • Spearman相关分析显示,除认知评分外,非运动症状评分与纹状体SUR相关(P < 0.05)。

临床怎么用

  • F-DTBZ PET/CT测定的纹状体VMAT2摄取率可用于评估帕金森病患者非运动症状相关的多巴胺能改变。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Nonmotor symptoms (NMS) are critical players in the patients' quality of life in Parkinson disease (PD). Vesicular monoamine transporter type 2 (VMAT2) has been reported owing to a role in affecting dopamine neurons in the striatum. Therefore, this study set out to characterize the relationship between VMAT2 distribution in the striatum in relation to the NMS in PD. METHODS: Totally, 21 age-matched normal controls and 37 patients with PD in the moderate stages were included, followed by examination using F-DTBZ (F-AV133) PET/CT. The specific uptake ratio (SUR) of each striatal subregion was then determined with the occipital cortex as the reference background region. The overall NMSs of each individual patient were evaluated. Finally, the role of the striatal SURs in the clinical symptom scores were evaluated through the application of a Spearman correlation analysis as well as a multivariable stepwise regression analysis. RESULTS: Patients with PD, particularly those at a more advanced stage, exhibited a more pronounced reduction in SURs in the bilateral putamen and caudate nucleus (P < 0.05, vs healthy controls). Meanwhile, patients at more advanced PD stages were found to have significantly worse scores in NMS except cognitive function. The Spearman correlation analysis demonstrated that NMS scores, with the exception of cognition scores, were correlated with striatal SURs (P < 0.05). CONCLUSION: The key findings of the study identified a correlation between decreased striatal VMAT2 with a broad spectrum of NMS in patients with PD, highlighting the association between diminished dopamine supply and the development of NMS in PD.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Shi X, Zhang Y, Xu S, et al. Decreased Striatal Vesicular Monoamine Transporter Type 2 Correlates With the Nonmotor Symptoms in Parkinson Disease. Clin Nucl Med. 2019. PMID: 31205154. doi:10.1097/RLU.0000000000002664

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。